NCT00566410
- Conditions
- Neoplasms
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
Clinical trial condition
Neoplasms
Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.
818 public trials
114 recruiting studies
Neoplasms trial results
NCT00005494
- Conditions
- Breast Diseases, Breast Neoplasms, Cardiovascular Diseases, +9 more
- Locations
-
Not specified
NCT01004393
- Conditions
- Chemically-Induced Disorders, Constipation, Mental Disorders, +8 more
- Locations
-
- Fletcher Allen Health Care Burlington, Vermont, United States
NCT02341846
- Conditions
- Cancer Pain, Neoplasms, Neurologic Manifestations, +3 more
- Locations
-
Not specified
NCT00900627
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
- Locations
-
- Research Site Brussels (Jette), Belgium
- Research Site Leuven, Belgium
- Research Site Namur, Belgium
- Research Site Sint-Niklaas, Belgium
NCT00487786
- Conditions
- Neoplasms
- Locations
-
- Seattle Cancer Care Alliance Seattle, Washington, United States
- BC Cancer Agency Vancouver, British Columbia, Canada
- Juravinski Cancer Center Hamilton, Ontario, Canada
NCT00141297
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Karmanos Cancer Institute Detroit, Michigan, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Abramson Cancer Center Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
- Pharmacy/PCAM/West Pavillion Philadelphia, Pennsylvania, United States
Completed
Yoga Cancer Rehabilitation Study: A Randomized Trial of Adaptive Yoga for Older Cancer Survivors
NCT01324102
- Conditions
- Neoplasms
- Locations
-
- VA Boston Healthcare System Brockton Campus, Brockton, MA Brockton, Massachusetts, United States
NCT00432302
- Conditions
- Neoplasms
- Locations
-
- Liège, Belgium
NCT01335269
- Conditions
- Neoplasms
- Locations
-
- 1300.2.1002 Boehringer Ingelheim Investigational Site Hamilton, Ontario, Canada
- 1300.2.1001 Boehringer Ingelheim Investigational Site Toronto, Ontario, Canada
- 1300.2.31003 Boehringer Ingelheim Investigational Site Amsterdam, Netherlands
- 1300.2.31001 Boehringer Ingelheim Investigational Site Rotterdam, Netherlands